- First off-the-shelf AdenoVerse immunotherapy targeting infectious disease to enter the clinic -
- RRP is a rare, difficult-to-treat neoplastic disease with no proven effective systemic therapy -
PR Newswire
GERMANTOWN, Md., Jan. 5, 2021
PR Newswire
GERMANTOWN, Md., Jan. 5, 2021
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey